|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
SCIDIR_on1223263892 |
| 003 |
OCoLC |
| 005 |
20231120010520.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
201122s2021 enk o 001 0 eng d |
| 040 |
|
|
|a YDX
|b eng
|e pn
|c YDX
|d UKAHL
|d OPELS
|d OCLCF
|d OCLCO
|d ABC
|d N$T
|d OCLCQ
|d OCLCO
|d K6U
|d OCLCQ
|d OCLCO
|
| 019 |
|
|
|a 1225355201
|
| 020 |
|
|
|a 9780128242056
|q (electronic bk.)
|
| 020 |
|
|
|a 0128242051
|q (electronic bk.)
|
| 020 |
|
|
|a 9780128238882
|
| 020 |
|
|
|a 0128238887
|
| 035 |
|
|
|a (OCoLC)1223263892
|z (OCoLC)1225355201
|
| 050 |
|
4 |
|a RM301.25
|
| 082 |
0 |
4 |
|a 615.1/9
|2 23
|
| 100 |
1 |
|
|a Rose, Klaus.
|
| 245 |
1 |
0 |
|a Considering the patient in pediatric drug development :
|b how good intentions turned into harm /
|c Klaus Rose.
|
| 260 |
|
|
|a London :
|b Academic Press,
|c 2021.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Includes index.
|
| 650 |
|
0 |
|a Drug development.
|
| 650 |
|
0 |
|a Pediatric pharmacology.
|
| 650 |
|
6 |
|a M�edicaments
|x D�eveloppement.
|0 (CaQQLa)201-0306620
|
| 650 |
|
6 |
|a Pharmacologie p�ediatrique.
|0 (CaQQLa)201-0000927
|
| 650 |
|
7 |
|a Drug development
|2 fast
|0 (OCoLC)fst00898670
|
| 650 |
|
7 |
|a Pediatric pharmacology
|2 fast
|0 (OCoLC)fst01056473
|
| 776 |
0 |
8 |
|i Print version:
|z 9780128242056
|
| 776 |
0 |
8 |
|i Print version:
|z 0128238887
|z 9780128238882
|w (OCoLC)1191715039
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128238882
|z Texto completo
|
